Project Title: Design of experiments-based development of lipid nanoparticle technology for miRNA delivery in non-invasive, targeted asthma therapy (miRNAsther)

Implemented under: The National Recovery and Resilience Plan, as part of Investment D3.1.1 Comprehensive development of research in medical sciences and health sciences, reference number: 2024/ABM/03/KPO/KPOD.07.07-IW.07-0117/24-00

Funding: Funded by the European Union under the National Recovery and Resilience Plan, supervised by the Ministry of Health – Intermediate Body: Medical Research Agency

Project implemented by:
Karol Marcinkowski Medical University in Poznań
Project Leader: Dr hab. Paulina Skupin-Mrugalska, PharmD

Project implementation period:
January 1, 2025 – March 31, 2026

Total project value:
PLN 14 996 578,75

EU funding amount:
PLN 14 996 578,75